GSK1265744
Sponsors
GlaxoSmithKline, ViiV Healthcare
Conditions
HIV InfectionHealthy SubjectsInfection, Human Immunodeficiency VirusInfections, Human Immunodeficiency Virus and Hepatitis
Phase 1
A Healthy Volunteer And Patient Study To Assess The Safety, Tolerability And Pharmacokinetics Of GSK1265744
CompletedNCT00659191
Start: 2008-02-29End: 2008-11-30Target: 58Updated: 2010-10-15
DDI Study of Etravirine and GSK1265744
CompletedNCT00920296
Start: 2009-07-31End: 2009-09-30Updated: 2010-08-31
A Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 and Rilpivirine and Dolutegravir and Rilpivirine in Healthy Adult Subjects
CompletedNCT01467531
Start: 2011-11-30End: 2012-02-29Updated: 2012-10-15
Study to Evaluate the Effect of GSK1265744 on Cardiac Conduction
CompletedNCT02027454
Start: 2014-01-31End: 2014-06-30Updated: 2014-06-16
Study to Evaluate the Pharmacokinetics of an Oral Contraceptive Containing Levonorgestrel and Ethinyl Estradiol When Co-administered With GSK1265744 in Healthy Adult Female Subjects
CompletedNCT02159131
Start: 2014-08-31End: 2014-12-31Updated: 2015-07-07